Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-25 @ 3:21 AM
NCT ID:
NCT07030205
Eligibility Criteria:
Inclusion Criteria (patients):
* Women aged 50 or over, with postmenopausal osteoporosis, fractured or not, diagnosed by their rheumatologist,
* Able to give informed consent to participate in the research,
* Affiliation with the French Social Security.
Inclusion Criteria (healthy volunteers):
* Women aged 50 or over,
* Bone densitometry performed as part of the protocol, not suggestive of osteoporosis and validated by investigators,
* Matched to patients by age, menopausal status, socio-educational level and manual laterality,
* Able to give informed consent to participate in the research,
* Affiliation with the French Social Security.
* Registration or acceptance of registration in the national register of volunteers participating in Research.
Exclusion Criteria (patient and healthy volunteers):
* Presence of pacemaker,
* Presence of medical devices (implants or prostheses),
* Incompatibility of the patient with the safety criteria of the medical imaging center for carrying out magnetic resonance experiments at 3 Tesla,
* Contraindications to the realization of MRI without injection such as claustrophobia proven, hearing aid, pacemaker wearers, wearing a brain clip,
* Refusal to be informed in the event of the accidental discovery of an anomaly during the resting state functional magnetic resonance imaging,
* Woman under legal protection or deprived of liberty,
* Refusal to participation
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
50 Years
Study:
NCT07030205
Study Brief:
Protocol Section:
NCT07030205